Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Common Equity (2020 - 2025)

Historic Common Equity for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $214.7 million.

  • MDxHealth's Common Equity rose 34.54% to $214.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $214.7 million, marking a year-over-year increase of 34.54%. This contributed to the annual value of $214.7 million for FY2024, which is 287821.86% up from last year.
  • As of Q3 2025, MDxHealth's Common Equity stood at $214.7 million, which was up 34.54% from $9.0 billion recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Common Equity ranged from a high of $9.0 billion in Q2 2025 and a low of $7.2 million during Q4 2023
  • Its 5-year average for Common Equity is $777.7 million, with a median of $173.5 million in 2023.
  • Per our database at Business Quant, MDxHealth's Common Equity tumbled by 8013.82% in 2022 and then skyrocketed by 507734.04% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Common Equity stood at $46.9 million in 2021, then tumbled by 80.14% to $9.3 million in 2022, then fell by 22.62% to $7.2 million in 2023, then surged by 2878.22% to $214.7 million in 2024, then changed by 0.0% to $214.7 million in 2025.
  • Its Common Equity was $214.7 million in Q3 2025, compared to $9.0 billion in Q2 2025 and $214.7 million in Q1 2025.